Bei Wang

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer

Sandhya Girish, Manish Gupta, Bei Wang et al. · Cancer Chemotherapy and Pharmacology · 2012 · 265 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Confirmation That Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro

Shu‐Ying Chang, Wenying Li, Sarah C. Traeger et al. · Drug Metabolism and Disposition · 2008 · 59 citations

Medicine, Pharmacokinetics, Pharmacology +15

Clinical pharmacology of vc-MMAE antibody–drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies

Chunze Li, Cindy Zhang, Zao Li et al. · mAbs · 2019 · 58 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

An Integrated Multiple-Analyte Pharmacokinetic Model to Characterize Trastuzumab Emtansine (T-DM1) Clearance Pathways and to Evaluate Reduced Pharmacokinetic Sampling in Patients with HER2-Positive Metastatic Breast Cancer

Dan Lu, Amita Joshi, Bei Wang et al. · Clinical Pharmacokinetics · 2013 · 43 citations

Pharmacy, Oncology, Pharmacokinetics +17

Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity

Bei Wang, Arabella Wan, Yu Xu et al. · Nature Communications · 2023 · 31 citations · Full text

Pharmacy, Pharmacology, Toxicology +13